Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products
Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products Drug alert number:EL (23)A/24 Date issued: 13 July 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Cipla (UK) Limited and Pharmathen S.A – Various Products Company name: Cipla (EU) Limited, [...]
The post Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products appeared first on Community Pharmacy England.
Recent Comments